mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.9 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.9 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |